Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis
dc.authorid | Akyurek, Fikret/0000-0002-8091-7737 | |
dc.contributor.author | Sen, Bilge Bulbul | |
dc.contributor.author | Rifaioglu, Emine Nur | |
dc.contributor.author | Ekiz, Ozlem | |
dc.contributor.author | Inan, Mehmet Ugur | |
dc.contributor.author | Sen, Tugba | |
dc.contributor.author | Sen, Nihat | |
dc.date.accessioned | 2024-09-18T20:27:59Z | |
dc.date.available | 2024-09-18T20:27:59Z | |
dc.date.issued | 2014 | |
dc.department | Hatay Mustafa Kemal Üniversitesi | en_US |
dc.description.abstract | Objective: Psoriasis is a chronic systemic inflammatory disorder. The neutrophil to lymphocyte ratio (N/L ratio) has been used as a marker for systemic inflammatory status. In our study, we aimed to evaluate N/L ratio in patients with psoriasis. Methods: This cross-sectional study population consisted of 138 patients with psoriasis and 120 age-and sex-matched control subjects. Results: The patients had significantly higher neutrophil counts and lower lymphocyte counts than the controls. The N/L ratios and high sensitivity C reactive protein (hs-CRP) levels were also significantly higher in patients. The N/L ratios and hs-CRP levels were increasing with increasing in Psoriasis Area and Severity Index score. Furthermore, the N/L ratios and hs-CRP levels of patients were found to be positively correlated. Conclusions: Our data show that the N/L ratio to be a simple, inexpensive and easily assessable marker of systemic inflammation in patients with psoriasis. | en_US |
dc.identifier.doi | 10.3109/15569527.2013.834498 | |
dc.identifier.endpage | 227 | en_US |
dc.identifier.issn | 1556-9527 | |
dc.identifier.issn | 1556-9535 | |
dc.identifier.issue | 3 | en_US |
dc.identifier.pmid | 24147939 | en_US |
dc.identifier.scopus | 2-s2.0-84906654414 | en_US |
dc.identifier.scopusquality | Q3 | en_US |
dc.identifier.startpage | 223 | en_US |
dc.identifier.uri | https://doi.org/10.3109/15569527.2013.834498 | |
dc.identifier.uri | https://hdl.handle.net/20.500.12483/10658 | |
dc.identifier.volume | 33 | en_US |
dc.identifier.wos | WOS:000341288800011 | en_US |
dc.identifier.wosquality | Q3 | en_US |
dc.indekslendigikaynak | Web of Science | en_US |
dc.indekslendigikaynak | Scopus | en_US |
dc.indekslendigikaynak | PubMed | en_US |
dc.language.iso | en | en_US |
dc.publisher | Taylor & Francis Ltd | en_US |
dc.relation.ispartof | Cutaneous and Ocular Toxicology | en_US |
dc.relation.publicationcategory | Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı | en_US |
dc.rights | info:eu-repo/semantics/closedAccess | en_US |
dc.subject | Inflammation | en_US |
dc.subject | neutrophil lymphocyte ratio | en_US |
dc.subject | psoriasis | en_US |
dc.title | Neutrophil to lymphocyte ratio as a measure of systemic inflammation in psoriasis | en_US |
dc.type | Article | en_US |
Dosyalar
Orijinal paket
1 - 1 / 1